Open Payments

THE STAMFORD HOSPITAL

Type
Teaching hospital
Where
Stamford, CT
Medicare CCN
070006
Received
$253,938 in 108 records, 2019 ($29,705 general, $224,232 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2019General payment29$29,705
2019Research payment79$224,232

By company

CompanyRecordsAmountYears
HOLOGIC INC7$38,9452019
Halozyme Inc3$36,2002019
Celgene Corporation5$29,7422019
F. Hoffmann-La Roche AG2$23,8292019
AKEBIA THERAPEUTICS INC28$20,4872019
Bayer Healthcare Pharmaceuticals Inc.8$14,1632019
Genentech, Inc.5$14,0162019
Janssen Research & Development, LLC1$11,4002019
Amgen Inc.3$10,7722019
CSL Behring3$9,5862019
Medtronic MiniMed, Inc.3$8,5752019
E.R. Squibb & Sons, L.L.C.4$7,3822019
Stryker Corporation17$6,7092019
Incyte Corporation3$5,9662019
Zimmer Biomet Holdings, Inc.1$4,6802019
Abbott Laboratories4$3,0162019
American Regent1$2,8002019
ABBVIE INC.1$1,0002019
Gilead Sciences, Inc.1$1,0002019
VERTEX PHARMACEUTICALS INCORPORATED1$1,0002019
Allergan, Inc.1$1,0002019
Boston Scientific Corporation3$9242019
Tandem Diabetes Care, Inc.2$6002019
Welch Allyn1$1412019

By nature of payment

NatureRecordsAmount
Research payment79$224,232
Compensation for services other than consulting, including serving as faculty or as a speaker at a v21$11,771
Gift3$8,934
Grant1$5,000
Space rental or facility fees (teaching hospital only)3$3,000
Education1$1,000

Records

DateCompanyAmountNatureFormProductStudyYear
2019-12-31Zimmer Biomet Holdings, Inc.$4,680GiftIn-kind items and servicesZimmer Biomet Instruments and Implants Device, General2019
2019-12-31Stryker Corporation$4,113GiftIn-kind items and servicesHIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET Device, ARTHROSCOPY2019
2019-12-20Medtronic MiniMed, Inc.$3,250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMinimed 670G System Device, Durable Pump2019
2019-12-19Janssen Research & Development, LLC$11,400Research paymentCash or cash equivalentA Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Lo2019
2019-12-13Bayer Healthcare Pharmaceuticals Inc.$1,834Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-12-10AKEBIA THERAPEUTICS INC$215Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-12-10AKEBIA THERAPEUTICS INC$215Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-12-10AKEBIA THERAPEUTICS INC$152Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-12-10Welch Allyn$141GiftCash or cash equivalent2019
2019-12-10AKEBIA THERAPEUTICS INC$126Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-12-06Genentech, Inc.$1,587Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyA PHASE III OF ATEZOLIZUMAB PLUS ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER2019
2019-12-03AKEBIA THERAPEUTICS INC$976Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-12-03AKEBIA THERAPEUTICS INC$493Research paymentCash or cash equivalentAKB-6548-CI-00142019
2019-12-02Boston Scientific Corporation$224Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTAPPRAISE ATP2019
2019-11-25HOLOGIC INC$5,000Research paymentCash or cash equivalent16-042019
2019-11-04AKEBIA THERAPEUTICS INC$952Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$887Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00142019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-11-04Genentech, Inc.$293Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2019
2019-10-30Celgene Corporation$2,500Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyConnect Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Regist2019
2019-10-30Abbott Laboratories$292Research paymentCash or cash equivalentCardioMEMS Device, Cardiac Arrhythmias and Heart FailureCardioMEMS HF System Post Approval Study2019
2019-10-29F. Hoffmann-La Roche AG$7,880Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2019
2019-10-24CSL Behring$6,461Research paymentCash or cash equivalentStudy to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II2019
2019-10-24CSL Behring$2,850Research paymentCash or cash equivalentStudy to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II2019
2019-10-24CSL Behring$275Research paymentCash or cash equivalentStudy to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II2019
2019-10-15Celgene Corporation$4,125Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyConnect MM- The Multiple Myeloma Disease Registry (OS002982)2019
2019-10-09Stryker Corporation$449Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-09Stryker Corporation$219Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-09Stryker Corporation$27Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-09Stryker Corporation$23Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-04Genentech, Inc.$921Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2019
2019-10-02AKEBIA THERAPEUTICS INC$854Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-09-16Boston Scientific Corporation$350Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTAPPRAISE ATP2019
2019-09-05HOLOGIC INC$2,799Research paymentCash or cash equivalentOryx 2 Device, Breast and Skeletal Health17-092019
2019-08-29Medtronic MiniMed, Inc.$3,525Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMinimed 670G System Device, Durable Pump2019
2019-08-08Bayer Healthcare Pharmaceuticals Inc.$2,155Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-08-07Amgen Inc.$1,807Research paymentIn-kind items and servicesNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC2019
2019-08-07Gilead Sciences, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2019
2019-08-06F. Hoffmann-La Roche AG$15,949Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2019
2019-08-06Halozyme Inc$6,473Research paymentCash or cash equivalentA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase 2019
2019-07-24Abbott Laboratories$520Research paymentCash or cash equivalentCardioMEMS Device, Cardiac Arrhythmias and Heart FailureCardioMEMS HF System Post Approval Study2019
2019-07-18HOLOGIC INC$4,286Research paymentCash or cash equivalentTrident HD Device, Breast and Skeletal Health17-052019
2019-07-16Stryker Corporation$329Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-16Stryker Corporation$159Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-16Stryker Corporation$38Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-16Stryker Corporation$21Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-08AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00142019
2019-06-24Medtronic MiniMed, Inc.$1,800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMinimed 670G System Device, Durable Pump2019
2019-06-21E.R. Squibb & Sons, L.L.C.$5,000GrantCash or cash equivalent2019
2019-06-13AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-05-30Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2019
2019-05-28Bayer Healthcare Pharmaceuticals Inc.$476Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-05-25Amgen Inc.$8,070Research paymentCash or cash equivalentNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC2019
2019-05-24HOLOGIC INC$5,000Research paymentCash or cash equivalent16-042019
2019-05-23Incyte Corporation$1,504Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-05-22Celgene Corporation$17,250Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyCelgene - Connect MM2019
2019-05-16E.R. Squibb & Sons, L.L.C.$90Research paymentCash or cash equivalentOPDIVO Biological, OncologyA Master Protocol of Phase II Studies of Nivolumab in Advanced NSCLC Nivolumab as Maintenance after Induction Chemothera2019
2019-05-07Bayer Healthcare Pharmaceuticals Inc.$3,736Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-05-07Bayer Healthcare Pharmaceuticals Inc.$2,586Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-05-07Bayer Healthcare Pharmaceuticals Inc.$1,293Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-05-07Bayer Healthcare Pharmaceuticals Inc.$1,293Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-05-07ABBVIE INC.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentCreon Drug, Endocrinology2019
2019-05-07Bayer Healthcare Pharmaceuticals Inc.$790Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2019
2019-05-06AKEBIA THERAPEUTICS INC$887Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-05-06AKEBIA THERAPEUTICS INC$887Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-05-06AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-05-06AKEBIA THERAPEUTICS INC$825Research paymentCash or cash equivalentAKB-6548-CI-00152019
2019-05-06AKEBIA THERAPEUTICS INC$734Research paymentCash or cash equivalentAKB-6548-CI-00142019
2019-05-06AKEBIA THERAPEUTICS INC$734Research paymentCash or cash equivalentAKB-6548-CI-00142019
2019-04-29Incyte Corporation$13Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-04-15HOLOGIC INC$3,760Research paymentCash or cash equivalentOryx 2 Device, Breast and Skeletal Health17-092019
2019-04-12Stryker Corporation$514Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-04-12Stryker Corporation$174Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-04-12Stryker Corporation$27Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-04-12Stryker Corporation$24Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-04-10E.R. Squibb & Sons, L.L.C.$2,112Research paymentCash or cash equivalentSPRYCEL Drug, OncologyStudying Interventions for Managing Patients With Chronic Myeloid Leukemia CML in Chronic Phase The 5-Year Prospective C2019
2019-04-10Abbott Laboratories$1,711Research paymentCash or cash equivalentCardioMEMS Device, Cardiac Arrhythmias and Heart FailureCardioMEMS HF System Post Approval Study2019
2019-04-10VERTEX PHARMACEUTICALS INCORPORATED$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSYMDEKO Drug, CYSTIC FIBROSIS2019
2019-04-08HOLOGIC INC$10,000Research paymentCash or cash equivalent16-042019
2019-03-21Halozyme Inc$16,538Research paymentCash or cash equivalentA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase 2019
2019-03-20Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2019
2019-03-18Boston Scientific Corporation$350Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTAPPRAISE ATP2019
2019-03-08Genentech, Inc.$1,843Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2019
2019-03-07Halozyme Inc$13,189Research paymentCash or cash equivalentA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase 2019
2019-03-04Allergan, Inc.$1,000EducationCash or cash equivalent2019
2019-02-20Genentech, Inc.$9,371Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2019
2019-02-19E.R. Squibb & Sons, L.L.C.$180Research paymentCash or cash equivalentOPDIVO Biological, OncologyA Master Protocol of Phase II Studies of Nivolumab in Advanced NSCLC Nivolumab as Maintenance after Induction Chemothera2019
2019-02-13American Regent$2,800Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2019
2019-02-05Incyte Corporation$4,449Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-01-22Celgene Corporation$1,367Research paymentCash or cash equivalentPomalyst Drug, Hematology / OncologyImmune profiling of relapsed or refractory multiple myeloma patients treated with pomalidomide and low-dose dexamethason2019
2019-01-18Celgene Corporation$4,500Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyCelgene - Connect MDSAML2019
2019-01-16Abbott Laboratories$492Research paymentCash or cash equivalentCardioMEMS Device, Cardiac Arrhythmias and Heart FailureCardioMEMS HF System Post Approval Study2019
2019-01-08Amgen Inc.$895Research paymentIn-kind items and servicesNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC2019
2019-01-08Stryker Corporation$419Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-01-08Stryker Corporation$117Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-01-08Stryker Corporation$27Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-01-08Stryker Corporation$20Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-01-02HOLOGIC INC$8,100Research paymentCash or cash equivalentOryx 2 Device, Breast and Skeletal Health17-092019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Western Connecticut Planning RegionStamford city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Stamford, CT, county Western Connecticut Planning Region, CT, state Connecticut; placed by its city name.

MeasurePlace (city or town)
Stamford, CT
County
Western Connecticut Planning Region, CT
State
Connecticut
Population B01003137,144627,0713,624,508
Population, 2020 census P1135,470-3,605,944
Median age B0100238.441.541.1
Under 18 B0100118.4%21.8%20.2%
65 and over B0100116.2%17.4%18.5%
Households B1100155,291235,3791,434,007
Foreign born B0500231.3%23.8%15.7%
Median household income B19013$111,586$128,188$95,781
Median family income B19113$126,493$161,625$122,706
Per capita income B19301$67,068$82,266$55,915
Poverty rate B1700110.1%7.5%10.0%
Unemployment rate B230254.9%5.3%5.6%
Civilian labor force B2302581,944346,5571,959,490
Mean commute (minutes) B0801328.530.826.5
Bachelor's degree or higher B1500351.7%55.5%42.5%
Housing units B2500158,655251,5301,541,822
Owner-occupied B2500348.8%66.4%66.5%
Renters B2500351.2%33.6%33.5%
Median home value B25077$624,400$652,900$366,900
Median gross rent B25064$2,276$2,110$1,488
White, not Hispanic B0300243.2%58.6%61.9%
Black B0300217.7%9.3%9.8%
Hispanic or Latino B0300228.3%20.5%18.3%
Asian B030027.3%5.4%4.7%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 5.1% in Sep 2026 (4.2% a year earlier); per capita personal income $102,307 in 2025, up 33% in five years (+7.1% after inflation); Unemployment rate: 4.7% in Sep 2016 to 5.1% in Sep 2026; low 3.1%, high 11.9% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Stamford, CT.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.